VITALHUB CORP (VHI.CA) Fundamental Analysis & Valuation

TSX:VHI • CA92847V5018

Current stock price

7.84 CAD
-0.23 (-2.85%)
Last:

This VHI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. VHI.CA Profitability Analysis

1.1 Basic Checks

  • In the past year VHI was profitable.
  • VHI had a positive operating cash flow in the past year.
  • Of the past 5 years VHI 4 years were profitable.
  • VHI had a positive operating cash flow in 4 of the past 5 years.
VHI.CA Yearly Net Income VS EBIT VS OCF VS FCFVHI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.73%, VHI belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • VHI has a Return On Equity of 2.30%. This is amongst the best in the industry. VHI outperforms 90.00% of its industry peers.
  • VHI has a Return On Invested Capital of 2.04%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 1.75%.
Industry RankSector Rank
ROA 1.73%
ROE 2.3%
ROIC 2.04%
ROA(3y)2.34%
ROA(5y)1.1%
ROE(3y)3.31%
ROE(5y)1.6%
ROIC(3y)2.82%
ROIC(5y)2.23%
VHI.CA Yearly ROA, ROE, ROICVHI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin of VHI (5.61%) is better than 100.00% of its industry peers.
  • VHI's Profit Margin has improved in the last couple of years.
  • The Operating Margin of VHI (10.74%) is better than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of VHI has grown nicely.
  • With an excellent Gross Margin value of 80.38%, VHI belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
  • VHI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.74%
PM (TTM) 5.61%
GM 80.38%
OM growth 3Y2.68%
OM growth 5YN/A
PM growth 3Y22.65%
PM growth 5YN/A
GM growth 3Y-0.83%
GM growth 5Y1.5%
VHI.CA Yearly Profit, Operating, Gross MarginsVHI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VHI.CA Health Analysis

2.1 Basic Checks

  • VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • VHI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VHI has more shares outstanding
  • Compared to 1 year ago, VHI has a worse debt to assets ratio.
VHI.CA Yearly Shares OutstandingVHI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VHI.CA Yearly Total Debt VS Total AssetsVHI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • VHI has an Altman-Z score of 4.29. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
  • VHI's Altman-Z score of 4.29 is fine compared to the rest of the industry. VHI outperforms 70.00% of its industry peers.
  • The Debt to FCF ratio of VHI is 0.32, which is an excellent value as it means it would take VHI, only 0.32 years of fcf income to pay off all of its debts.
  • VHI's Debt to FCF ratio of 0.32 is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
  • VHI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • VHI has a Debt to Equity ratio of 0.01. This is in the better half of the industry: VHI outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.32
Altman-Z 4.29
ROIC/WACC0.25
WACC8.13%
VHI.CA Yearly LT Debt VS Equity VS FCFVHI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that VHI has no problem at all paying its short term obligations.
  • VHI's Current ratio of 2.40 is fine compared to the rest of the industry. VHI outperforms 70.00% of its industry peers.
  • A Quick Ratio of 2.40 indicates that VHI has no problem at all paying its short term obligations.
  • VHI has a Quick ratio of 2.40. This is in the better half of the industry: VHI outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.4
VHI.CA Yearly Current Assets VS Current LiabilitesVHI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. VHI.CA Growth Analysis

3.1 Past

  • VHI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.29%, which is quite good.
  • Measured over the past years, VHI shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.72% on average per year.
  • VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 58.86%.
  • Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 51.19% on average per year.
EPS 1Y (TTM)14.29%
EPS 3Y35.72%
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)58.86%
Revenue growth 3Y39.7%
Revenue growth 5Y51.19%
Sales Q2Q%52.45%

3.2 Future

  • VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 99.65% yearly.
  • The Revenue is expected to grow by 16.07% on average over the next years. This is quite good.
EPS Next Y218.43%
EPS Next 2Y99.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.44%
Revenue Next 2Y14.82%
Revenue Next 3Y16.07%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VHI.CA Yearly Revenue VS EstimatesVHI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
VHI.CA Yearly EPS VS EstimatesVHI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. VHI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • VHI is valuated quite expensively with a Price/Earnings ratio of 98.00.
  • 100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
  • VHI is valuated expensively when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 30.78, the valuation of VHI can be described as expensive.
  • VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 90.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.62. VHI is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 98
Fwd PE 30.78
VHI.CA Price Earnings VS Forward Price EarningsVHI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
  • VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 62.78
EV/EBITDA 14.58
VHI.CA Per share dataVHI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VHI has an outstanding profitability rating, which may justify a higher PE ratio.
  • VHI's earnings are expected to grow with 99.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y99.65%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VHI.CA Dividend Analysis

5.1 Amount

  • VHI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VHI.CA Fundamentals: All Metrics, Ratios and Statistics

VITALHUB CORP

TSX:VHI (4/23/2026, 7:00:00 PM)

7.84

-0.23 (-2.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-18
Earnings (Next)05-07
Inst Owners35.22%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap495.88M
Revenue(TTM)108.97M
Net Income(TTM)6.11M
Analysts81.43
Price Target12.88 (64.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-42.55%
Min EPS beat(2)-129.12%
Max EPS beat(2)44.01%
EPS beat(4)1
Avg EPS beat(4)-41.93%
Min EPS beat(4)-129.12%
Max EPS beat(4)44.01%
EPS beat(8)1
Avg EPS beat(8)-47.96%
EPS beat(12)2
Avg EPS beat(12)-32.04%
EPS beat(16)3
Avg EPS beat(16)-33.35%
Revenue beat(2)2
Avg Revenue beat(2)6.65%
Min Revenue beat(2)0.64%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)5.29%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)7
Avg Revenue beat(8)4.31%
Revenue beat(12)10
Avg Revenue beat(12)3.98%
Revenue beat(16)13
Avg Revenue beat(16)4.21%
PT rev (1m)-11.87%
PT rev (3m)-16.97%
EPS NQ rev (1m)-8.77%
EPS NQ rev (3m)-8.77%
EPS NY rev (1m)1.91%
EPS NY rev (3m)5.09%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 98
Fwd PE 30.78
P/S 4.55
P/FCF 62.78
P/OCF 59.59
P/B 1.86
P/tB 7.75
EV/EBITDA 14.58
EPS(TTM)0.08
EY1.02%
EPS(NY)0.25
Fwd EY3.25%
FCF(TTM)0.12
FCFY1.59%
OCF(TTM)0.13
OCFY1.68%
SpS1.72
BVpS4.2
TBVpS1.01
PEG (NY)0.45
PEG (5Y)N/A
Graham Number2.75097 (-64.91%)
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 2.3%
ROCE 4.01%
ROIC 2.04%
ROICexc 3.44%
ROICexgc N/A
OM 10.74%
PM (TTM) 5.61%
GM 80.38%
FCFM 7.25%
ROA(3y)2.34%
ROA(5y)1.1%
ROE(3y)3.31%
ROE(5y)1.6%
ROIC(3y)2.82%
ROIC(5y)2.23%
ROICexc(3y)4.5%
ROICexc(5y)3.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.55%
ROCE(5y)4.39%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y3.47%
ROICexc growth 5YN/A
OM growth 3Y2.68%
OM growth 5YN/A
PM growth 3Y22.65%
PM growth 5YN/A
GM growth 3Y-0.83%
GM growth 5Y1.5%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.32
Debt/EBITDA 0.09
Cap/Depr 3.82%
Cap/Sales 0.39%
Interest Coverage 250
Cash Conversion 36.51%
Profit Quality 129.25%
Current Ratio 2.4
Quick Ratio 2.4
Altman-Z 4.29
F-Score5
WACC8.13%
ROIC/WACC0.25
Cap/Depr(3y)8.15%
Cap/Depr(5y)8.36%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.8%
Profit Quality(3y)349.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.29%
EPS 3Y35.72%
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y218.43%
EPS Next 2Y99.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)58.86%
Revenue growth 3Y39.7%
Revenue growth 5Y51.19%
Sales Q2Q%52.45%
Revenue Next Year20.44%
Revenue Next 2Y14.82%
Revenue Next 3Y16.07%
Revenue Next 5YN/A
EBIT growth 1Y24.77%
EBIT growth 3Y43.44%
EBIT growth 5YN/A
EBIT Next Year57.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.55%
FCF growth 3Y10.67%
FCF growth 5Y93.12%
OCF growth 1Y-44.99%
OCF growth 3Y10.77%
OCF growth 5Y83.04%

VITALHUB CORP / VHI.CA Fundamental Analysis FAQ

What is the fundamental rating for VHI stock?

ChartMill assigns a fundamental rating of 7 / 10 to VHI.CA.


What is the valuation status for VHI stock?

ChartMill assigns a valuation rating of 7 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Undervalued.


What is the profitability of VHI stock?

VITALHUB CORP (VHI.CA) has a profitability rating of 8 / 10.


How financially healthy is VITALHUB CORP?

The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.


Can you provide the expected EPS growth for VHI stock?

The Earnings per Share (EPS) of VITALHUB CORP (VHI.CA) is expected to grow by 218.43% in the next year.